COVID-19 pneumonia in lung transplant recipients : Report of 2 cases
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons..
Coronavirus disease 2019 (COVID-19) has been declared pandemic since March 2020. In Europe, Italy was the first nation affected by this infection. We report anamnestic data, clinical features, and therapeutic management of 2 lung transplant recipients with confirmed COVID-19 pneumonia. Both patients were in good clinical condition before the infection and were receiving immunosuppression with calcineurin inhibitors (CNI), mycophenolate mofetil, and corticosteroids. Whereas mycophenolate mofetil was withdrawn in both cases, CNI were suspended only in the second patient. The first patient always maintained excellent oxygen saturation throughout hospitalization with no need for additional oxygen therapy. He was discharged with a satisfactory pulmonary function and a complete resolution of radiological and clinical findings. However, at discharge SARS-CoV-2 RNA could still be detected in the nasopharyngeal swab and in the stools. The second patient required mechanical ventilation, had a progressive deterioration of his clinical conditions, and had a fatal outcome. Further insight into SARS-CoV-2 infection is eagerly awaited to improve the outcome of transplant recipients affected by COVID-19 pneumonia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 20(2020), 10 vom: 24. Okt., Seite 2933-2937 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cozzi, Emanuele [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 14.10.2020 Date Revised 06.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/ajt.15993 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM30983094X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM30983094X | ||
003 | DE-627 | ||
005 | 20231225134756.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/ajt.15993 |2 doi | |
028 | 5 | 2 | |a pubmed24n1032.xml |
035 | |a (DE-627)NLM30983094X | ||
035 | |a (NLM)32400074 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cozzi, Emanuele |e verfasserin |4 aut | |
245 | 1 | 0 | |a COVID-19 pneumonia in lung transplant recipients |b Report of 2 cases |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.10.2020 | ||
500 | |a Date Revised 06.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 The American Society of Transplantation and the American Society of Transplant Surgeons. | ||
520 | |a Coronavirus disease 2019 (COVID-19) has been declared pandemic since March 2020. In Europe, Italy was the first nation affected by this infection. We report anamnestic data, clinical features, and therapeutic management of 2 lung transplant recipients with confirmed COVID-19 pneumonia. Both patients were in good clinical condition before the infection and were receiving immunosuppression with calcineurin inhibitors (CNI), mycophenolate mofetil, and corticosteroids. Whereas mycophenolate mofetil was withdrawn in both cases, CNI were suspended only in the second patient. The first patient always maintained excellent oxygen saturation throughout hospitalization with no need for additional oxygen therapy. He was discharged with a satisfactory pulmonary function and a complete resolution of radiological and clinical findings. However, at discharge SARS-CoV-2 RNA could still be detected in the nasopharyngeal swab and in the stools. The second patient required mechanical ventilation, had a progressive deterioration of his clinical conditions, and had a fatal outcome. Further insight into SARS-CoV-2 infection is eagerly awaited to improve the outcome of transplant recipients affected by COVID-19 pneumonia | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a clinical research/practice | |
650 | 4 | |a immunosuppressant | |
650 | 4 | |a immunosuppression/immune modulation | |
650 | 4 | |a infection and infectious agents - viral | |
650 | 4 | |a lung disease: infectious | |
650 | 4 | |a lung transplantation/pulmonology | |
650 | 7 | |a Immunosuppressive Agents |2 NLM | |
700 | 1 | |a Faccioli, Eleonora |e verfasserin |4 aut | |
700 | 1 | |a Marinello, Serena |e verfasserin |4 aut | |
700 | 1 | |a Loy, Monica |e verfasserin |4 aut | |
700 | 1 | |a Congedi, Sabrina |e verfasserin |4 aut | |
700 | 1 | |a Calabrese, Fiorella |e verfasserin |4 aut | |
700 | 1 | |a Romagnoli, Micaela |e verfasserin |4 aut | |
700 | 1 | |a Cattelan, Anna M |e verfasserin |4 aut | |
700 | 1 | |a Rea, Federico |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons |d 2001 |g 20(2020), 10 vom: 24. Okt., Seite 2933-2937 |w (DE-627)NLM119667924 |x 1600-6143 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2020 |g number:10 |g day:24 |g month:10 |g pages:2933-2937 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/ajt.15993 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2020 |e 10 |b 24 |c 10 |h 2933-2937 |